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EXECUTIVE SUMMARY

Since 1999, the contraceptive prevalence rate (CPR)
for modern methods in Nigeria has stalled at 8–10%.
Maternal, neonatal and child health indices remain
abysmally low with maternal and infant mortality
ratios of 545/100,000 and 89/1,000 live births
respectively. This is a result of multiple contributing factors such as lack of availability and access
to long-acting contraceptive commodities, as well
as a dearth of skilled service providers that can
provide a wide range of methods to satisfy every
woman’s needs. Currently, attention is being given
to increased funding and commitment for family
planning and reproductive health services, including
the deployment of new technologies in developing
countries, to mitigate the problem of unmet need
for contraception and to improve maternal and child
health. In line with this trend, the Council is conducting a three-year acceptability study of the progesterone vaginal ring (PVR) in three sub-Saharan African
Countries—Nigeria, Senegal, and Kenya. The Council
research teams conducted assessments to map out
the current family planning programs and contraceptive technologies landscape to identify national
priorities, evaluate stakeholder interest in the PVR,
and devise appropriate pre-introductory activities.
In Nigeria, the research team utilized three approaches to develop this country-specific report:
review of available data; desk review of documents,

project reports and policy guidelines; and key informant interviews. The interviews were held with government officials, regulatory and development agencies,
social marketing organizations, research institutions,
advocacy groups, manufacturers and distributors,
policymakers, and other members of the community.
This report lays out Nigeria’s demographics and
high fertility rates, describes the family planning
program and policy context, and finally, reveals the
stakeholder support thus far with a discussion on how
best to proceed with introduction activities.
This country mapping confirms the likelihood that
the PVR would be well received in Nigeria and fill
a large need in family planning. The PVR is a safe,
long-acting, user-controlled product that can be easily inserted and removed by the woman herself with
minimal coaching; this is especially appropriate for
women in the North who frequent healthcare facilities
sparingly due to an aversion to male healthcare providers, need for permission from male partners to visit
health facilities, poverty, and a lack of skilled health
personnel. The quick return to fertility after discontinuation of use makes the PVR a promising prospect for
expanding contraceptive choice for women in Nigeria.
All of these characteristics make the PVR a highly desirable addition to the current contraceptive method
mix in Nigeria.

v
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INTRODUCTION
While the progress made in recent decades in fertility
reduction has been impressive, up to 222 million women in the developing world still report an unmet need
for contraception (Singh and Darroch 2013). Part of the
challenge in addressing current levels of unmet need is
the limited use of contraception by women during the
first six to 12 months postpartum and the discontinuation rates, with about half of all users abandoning
their methods six months after adoption. Both issues
lead to limited success in effective birth spacing, which
then impacts maternal and infant health. New methods
are needed that offer greater ease of use, are womencontrolled, and do not require significant health infrastructure or medical provider involvement for service
delivery. One such method is the progesterone vaginal
ring (PVR), a user-controlled, mid-acting contraceptive
that, according to clinical trial data, is safe and effective
for breastfeeding women.
The Population Council has embarked on a threeyear project to explore the acceptability of the PVR
among women, their partners, and providers in sub-Saharan Africa and to develop a strategy for its introduction. From February to May 2012 assessments were
undertaken in Kenya, Nigeria, and Senegal—potential
countries for PVR introduction—to map the landscape
of family planning programs and new contraceptive
technologies to identify national priorities, and to assess the level of interest in the product among stakeholders and to design appropriate pre-introductory
activities. The Council’s research teams in each of
these countries employed three approaches to develop
country-specific reports: a review of Demographic and
Health Survey (DHS) data; a desk review of documents,
project reports and policy guidelines; and key informant interviews. Interviews were held with representatives of government, regulatory, and development
agencies; social marketing organizations; research
institutions; manufacturers/distributors; the community; advocacy groups; public/private partnerships;
other organizations providing family planning services;
and policymakers. This report presents the findings
from Nigeria and begins by describing the country
demographic profile and unmet need for contraception.
It then provides the family planning program and policy
context, and concludes with the stakeholder support
known thus far and a discussion for what this means
moving forward.

DEMOGRAPHIC PROFILE
Nigeria is the most populous country in Africa. With a
population growth rate of 2.5%, the population is projected to reach 433 million by the year 2050, making it
the third most populous country in the world, after India
and China (Population Reference Bureau 2011).
Although both maternal and infant mortality rates
are very high (545/100,000 and 89/1,000 respectively), contraceptive prevalence rate (CPR) for modern

DEMOGRAPHIC SNAPSHOT
Population: 162 million
Projected
	population in 2050: 433 million
Growth rate: 2.5%
Total fertility rate: 5.7 children per woman
		 (up to 7.3 in Northwest 		
		 zone)
Maternal
	mortality ratio: 545/100,000
Infant
	mortality rate: 89/1,000
Births occurring
withIN 24 months
	after prior birth: 24%
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methods has not increased significantly since 1999;
6.8% in 1999 and 9.7% presently (NPC and ICF Macro
2009). This rate is not uniform across the country—in
some parts of northern Nigeria, the contraceptive prevalence rate is as low as 2.5% (NPC and ICF Macro 2009).

childbearing and
contraceptive
behavior

about modern contraceptives identified several negative implications of their use. Women expressed the
belief that contraception causes mahaifan kulle [locked
womb] and that extended use leads to a permanent
loss of fertility—both serious consequences in a society where fertility is so highly valued. They also voiced
concerns that modern contraceptives are injurious to
women’s health, possibly being laced with substances
that cause cancer, result in birth defects, and lead to
sexually transmitted infections (Caldwell and Caldwell
1987).

Existing socio-cultural norms place a high value on fertility, encourage early marriage, limit women’s equality,
place the power to decide who receives services in the
hands of the provider, and support polygamy (Izugbara
and Ezeh 2010; Caldwell and Caldwell 1987). Nigeria
has a high fertility rate of 5.7, with some areas in the
Northwest being higher. Studies have linked the Northern region’s high fertility to early marriage, of which it
has one of the highest rates in the world; lack of information about and access to family planning methods;
men’s dominant roles as household decisionmakers;
and polygyny. Polygyny encourages women to have more
children than their co-wives to ensure that they will
receive the largest share of the husband’s resources in
the event anything should happen to him (Caldwell and
Caldwell 1987).

The country’s health infrastructure also plays a large
role in maintaining the existing level of contraceptive
use. Commodity shortages, weak logistics systems, and
inadequate provider knowledge and skills impede the
delivery of effective family planning services. Furthermore overall funding for the health sector is low; and under health-sector reform, greater programmatic authority has been transferred to lower levels that have limited
capacity. These decentralized bodies do not have the
required capabilities to plan, design, and implement
effective services.

Compounding this need to have more children in
order to secure greater economic and social status is
the grave fear of infertility. A woman who can, or is expecting to reproduce again is regarded differently from
a woman who cannot or does not want to. Even “behavioral barrenness,” (Izugbara and Ezeh 2010) where one
arranges or expresses the intention to no longer reproduce, has been looked down upon because of the way
status is conferred upon families based on their number
of children. As the Chairman of the Senate Committee
on Health affirmed, “large family size ostensibly symbolizes and begets wealth, influence, respect, and fame”.3
However, despite the traditional importance attached
to fertility, many women do not support unregulated
childbearing as they are aware of the physical risk associated with high fertility and closely spaced births, and
the social and economic consequences of large families
(Caldwell and Caldwell 1987).

The national health system is organized into a threetiered service delivery system of primary, secondary,
and tertiary levels, which are the responsibility of the
local, state, and federal governments, respectively. Primary care is the entry point into the healthcare system;
the secondary level focuses on general and specialist
care; while the tertiary level covers teaching hospitals,
federal medical centers, orthopedic hospitals, and
psychiatric hospitals. The structure aims to serve the
needs of the population but there are numerous lapses
in practice.

Unfortunately, there is a pervasive misconception in
Nigeria that there are many negative health implications
associated with the use of modern contraceptives. A
qualitative study of Northern Nigerian women’s beliefs
2

HEALTH SYSTEMS
STRUCTURE

Each state is required to have at least one tertiary
care facility, but most people access their care through
the most basic primary health care (PHC) facilities.
Although up to 71% of Nigerians have access to a PHC
facility located within 5 kilometers of their homes, many
of these service delivery centers experience frequent
supply stockouts, lack proper equipment and other essential supplies, and have underqualified staff.
Due to the limitations of public health care, private
facilities can assure a certain standard of quality care.
However, only 30% of Nigerians visit private facilities

Figure 1: Structure of the healthcare system in Nigeria
Tertiary level

SECONDARY level

PRIMARY CARE

Teaching Hospital, Federal Medical Centers, Psychiatrics

General Hospitals

Primary Health
Care Centers

for health care services. Despite this, the private sector
in Nigeria provides upwards of 60% of family planning services, and is a dominant source for delivery of
contraceptive (Tien et al. 2009); nonetheless, the public
sector represents a large window of opportunity for scaling up the delivery and distribution of this technology
because of its capacity and proximity to more than 70%
of Nigerians.

FAMILY PLANNING AND
REPRODUCTIVE HEALTH
POLICY CONTEXT
In response to the recognition that a high population
growth rate is detrimental to national development, the
government of Nigeria approved the National Policy on
Population for Development in 1988. A strong family
planning program was called for as an integral component of this policy. However, emerging issues such as
HIV/AIDS, poverty, and gender mainstreaming programs
detracted attention and funds away from the development of a federal family planning program. Progress in
the areas of family planning and reproductive health
stagnated, so, in 2005, the government launched an
updated version of this policy, termed the National
Policy on Population for Sustainable Development.
The goal of the 2004 Revised National Health Policy
was to improve the quality of life and the standard
of living for the population by reducing the national
population growth rate; the total fertility rate; the infant,
child and maternal mortality rates; and the prevalence
of HIV/AIDS, while increasing the number of females
enrolled in school and the literacy rate.
The 2004 Revised National Health Policy outlines the
various roles and responsibilities of the different levels

Health Posts

State Specialist Hospitals

Comprehensive
Health Centers

of government and other organizations operating in the
country to deliver or facilitate delivery of health services,
including nongovernmental organizations. It also laid
out programmatic strategies for ensuring a functional
referral system through which people can access the
appropriate care from primary, secondary, or tertiary
facilities. The central government was to provide overall
programmatic direction, and the state and local governments were to work with the various health-related
ministries and departments at state and local levels,
development agencies, and other relevant institutions
to adopt and implement these policies and programs.
Investments in the family planning program have not
increased, challenges remain with commodity security,
and the existing method mix is considered limited.

Contraceptive Use and Method Mix
Real and perceived barriers prevent many women from
accessing health services, including family planning services. The NDHS 2008 report showed that poverty was
the main perceived barrier to accessing health services
among women (56%), a 26 percentage point increase
over the finding in the 2003 NDHS (30%). Other disenabling factors to access care include perceived lack of
drugs, transport, and distance to the health facilities
(33%), preference for a female provider (20%), and
obtaining permission to visit healthcare facilities (10%)
(NPC and ICF Macro 2009). While social and gender
norms play a role in which populations utilize reproductive health and family planning services, income level
does as well. Married women in the richest quintile are
more likely to use a modern contraceptive (21%) than
those in the poorest quintile (4%) (Caldwell and Caldwell
1987). This statistic highlights just one of the many
barriers that keep women in Nigeria from utilizing what
reproductive health and family planning services, if any,
may be available to them. Consequently, and as can be
3

Figure 2: CHART SHOWING MethoDS MIX IN NIGERIA AS OF 2008
CONTRACEPTIVE METHODS USE % (NDHS 2008)

Female sterilization
Pill
IUD
Injectables

that IUCD insertion requires
some level of intimate contact
between the clients and providers, religious and cultural
reasons in the predominantly
Muslim north may play a role
in the widespread aversion
toward IUCDs.

Anecdotal evidence suggests that the male condom is
commonly used by young unFemale condom
married people, not necessarLAM
ily as a contraceptive method,
Rhythm
but as protection against STIs.
Withdrawal
It is not particularly favored in
Folk method
marital relationships because
of the long-held belief that it
reduces sexual satisfaction
and a relatively high failure
rate in typical use. Additionally, the female condom has
not enjoyed much popularity among women beyond its
introductory phase. The uptake of combined oral contraceptive pills for many women is limited. The delay in
return of fertility following prolonged use of injectables
makes them unappealing to women in need of child
spacing, due to the anxiety over such delays.
Implants

Male condom

seen in Figure 2 below, only 15% of women of reproductive age use any method of contraception, 10% are using modern methods and 85% are not using any method
at all (NPC and Macro ICF 2009).
Modern contraceptives available in the program
include barrier methods (male and female condoms),
IUCDs, combined oral contraceptive pills (Exluton and
Microgynon), injectables (Depo Provera and Noristerat),
implants (Implanon and Jadelle), and female sterilization, while traditional or natural methods include the
lactational amenorrhea method (LAM), rhythm method,
withdrawal method, and folk method.
According to the Nigeria Demographic and Health
Survey (2008), 3% of married women use injectables
and 2% use pills, male condom, and LAM each, while
1% uses IUCDs. There appears to be a preference
toward long- or mid-acting methods as can be inferred
from the higher use of injectables (although only 3%).
Preference for one contraceptive over another varies
across the country. Married women in the South prefer IUCDs, whereas their northern counterparts prefer
injectables. IUCD insertion and removal require a more
sophisticated health infrastructure in terms of equipment and skilled providers, which are available more
in the south. On the other hand, there is a dearth of
skilled personnel in the north, and this, combined with
poor health-seeking behavior, implies that northern
clients may be content with other methods such as oral
pills and injectables, which can be obtained at a nearby
patient medical store. Furthermore, due to the fact
4

Women may overcome social, economic, and other
barriers to reach a health facility but encounter additional provider and medical barriers upon reaching it.
Due to the lack of skilled and trained service providers
in IUCD and implant insertion and removal, especially at
the lower-level facilities, these methods are often not offered. Providers too have biases and preferences for certain methods. For example, providers have been known
to be judgmental and reluctant to serve single men and
women, especially youths. They reflect the cultural context of widespread belief that the use of contraceptives
encourages female promiscuity as it reduces the risk of
consequences (unintended pregnancy).
In addition, women in Northern Nigeria seeking modern contraceptives at clinics are often asked to come in
with their husbands. As some women may wish to keep
their family planning intentions to themselves and prefer
covert contraceptive use, this practice prevents these
women from accessing services (Caldwell and Caldwell
1987).
From the foregoing discussion, it can be seen that
the contraceptive environment in Nigeria is plagued by
a myriad of obstacles ranging from inadequate provid-

ers’ skills to lack of adequate supply of all methods from
which a prospective user can chose. Although the Population Council, as part of the International Contraceptive
Access (ICA) Foundation, has been in partnership with
some service-providing nongovernmental organizations,
such as Pathfinder International, Rotary International,
Marie Stopes, and IPPF, to increase access to the
Levonorgestrel intra-uterine system (LNG IUS)—a form
of IUCD—in Nigeria (part of an effort to expand method
mix), and while demand for LNG IUS is steadily rising,
the gap that needs to be filled is still wide. We hope that,
introducing the PVR into Nigeria’s program will contribute to alleviating this difficulty.

Previous Experiences of Contraceptive
Introduction in Nigeria
The subdermal implant, Jadelle, was the last contraceptive method to appear in Nigeria’s family planning
program. It was launched as an improved version of
Norplant, which was introduced in 1985, and thus was
not subject to a formal introductory process. The product
was well received by policymakers, providers, and clients
alike as it provided an additional long-acting noncoital dependent option with only two rods as opposed
to Norplant with six rods. However, issues related to
Jadelle’s availability and affordability have impeded its
widespread introduction. When Jadelle was introduced,
it was freely distributed to stakeholders and clients,
however, this was short lived. After the introductory
phase, Nigerians could not afford the product at private
market costs, which were around N1,000 (USD $6)—beyond the purchasing power of ordinary Nigerians. The
product is not very prevalent in the current method mix.
However, as of 7 April 2011, all contraceptive commodities are free in Nigeria provided that they are accessed
at a public facility. To what extent this policy is affecting
supply and demand of Jadelle is yet undetermined. However, in general, continuous availability of contraceptive
commodities is still an issue in Nigeria.

breastfeeding policies
and practices
Despite overwhelming evidence in favor of exclusive
breastfeeding, only 13% of infants in Nigeria are exclusively breastfed to the age of six months (Federal Ministry of Health, 2011). Although almost all infants were
breastfed (97%), less than half of the infants (38%) were

put to breast within one hour of delivery, and only 68%
commenced breastfeeding within the first day (NPC and
ICF Macro 2009). At the national level, the median duration of exclusive breastfeeding is less than one month
across all zones, wealth quintiles, and mother’s education levels, and the median duration of predominant
breastfeeding (with the addition of water and juices)
is just three months. Traditionally, Nigerian women
continue to breastfeed for up to two years, but the duration of both exclusive and predominant breastfeeding
is shortening. According to the Nigerian Demographic
and Health Survey (2008), the proportion of exclusively
breastfed infants less than six months of age fell from
17% in 2003 to 13% in 2008. The median duration of
breastfeeding is 18 months though slightly longer in
rural areas (19 months) in comparison to urban areas
(16 months). Almost all breastfeeding children less than
6 months of age were breastfed at least six times in a
24-hour period (NPC and ICF Macro 2009). Women in
the highest wealth quintile had weaned their baby completely by the age of 14 months. The median duration of
postpartum amenorrhea is 11 months, although shorter
in urban (8 months) than in rural areas (13 months).By
as early as 8 months, 77% of mothers have resumed
sexual intercourse (NPC and ICF Macro 2009). The
median duration of postpartum abstinence is also very
short at about 4 months with wide regional variation, 5
months in all southern regions, 2 months for the north
east and north west and 7 months for north central
region (NDHS, 2008).
The use of milk formula and other replacements
for breast milk is on the rise among some women and
HIV-positive women who have stopped breastfeeding
altogether as part of the Prevention of Mother-to-Child
Transmission (PMTCT) strategy. A survey conducted in
2008 revealed that only 7% of all breastfeeding children
under the age of three consume infant formula (NPC
and ICF Macro 2009), and a higher proportion (24%)
receives other forms of milk, mainly cow and goat. The
high price of milk formula, which ranges from $6 to $12
per sachet, may be responsible for the low intake rates
despite the rising need for such products. A majority of
the population is likely unable to afford infant formula
even when required, given that the proportion of the
population living on less than $2 a day is 84% (Population Reference Bureau 2010).
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SECURING CONTRACEPTIVE
COMMODITIES AND
GETTING THEM TO
MARKET
Commodity Procurement Process
Neither the Federal Ministry of Health (FMoH) nor its
Department of Family Health is involved in direct family
planning commodities procurement; all family planning
commodities come from donors. Procurement of reproductive health and family planning commodities has
historically never been included in the national budget.
A policy breakthrough was achieved in FY2012 when FP
commodities where included in the budget for the first
time. It remains to be seen if this addition to the budget
will result in improvements in family planning performance indicators. Many states also do not have funds
dedicated to family planning and reproductive health.
The system relies entirely on donations from the United
Nations Population Fund (UNFPA) for public-sector family planning commodities; while the UK Department for
International Development (DfID) and the United States
Agency for International Development (USAID) provide
private-sector support (Tien et al. 2009).
The Contraceptive Logistic Management Section
(CLMS) of the FMoH works closely with UNFPA to manage, track, and distribute contraceptive commodities.
Other nongovernmental organizations, such as Planned
Parenthood Federation of Nigeria (PPFN) and the Association for Reproductive and Family Health (ARFH),
also access and purchase public-sector contraceptives
through direct request to the central level. The Requisition Issue Forms (RIFs) and Requisition, Issue, and
Report Forms (RIRFs) serve as proxy mechanisms to
determine the amount of supplies needed using established maximum and minimum guidelines. The country
commodity manager monitors the pipeline and issues
trends annually; information that is tracked centrally.
States, local governments, and service delivery points
order their own commodities.
Independent of which commodity is procured;
distribution is done from the center to the periphery:
state governments, local governments, and then service
delivery points. While local governments order quarterly,
the service delivery points do so every two months.
However, this ordering and distribution pathway is not
seamless. All government levels fail to budget for con6

traception, so even donated commodities may not be
transported to the needed points due to lack of funds to
cover transportation costs. In 2002, the CLMS adopted
the “Strategic Pathway to Reproductive Health Commodity Security” (SPARHCS) framework, a cost-recovery
system to secure essential commodities for family planning and reproductive health programs. Unfortunately,
issues with policy, financing, coordination, logistics, demand creation, and service delivery have prevented this
SPARHCS from effecting any change, and challenges
remain in ensuring a consistent supply of commodities.
Due to low demand for family planning services, money
recovered from sale is not enough to maintain the
system; transportation costs are covered solely by the
cost-recovery system and not by any government source.
Thus, it is common to experience nationwide commodity
stock-out despite adequate stock at the central contraceptive warehouse.

Product Registration
In Nigeria, only the manufacturer can register a product,
but a waiver can be obtained. The Standard Operating
Procedures (SOPs) ensure that contraceptives meet
quality standards while the National Agency for Foods,
Drugs Administration, and Control (NAFDAC) is the
statutory body responsible for monitoring the quality
of contraceptives imported into the country. Under its
pharmaco-vigilence initiative, the NAFDAC is responsible
for updating the safety profile of all drugs and medicine.
If research needs to be conducted, the National Institute
for Medical Research (NIMR) must approve and monitor
the research. Once a product is cleared, the FMoH (and
thus the federal government) accept the product for its
intended use.

Support for the PVR
Perception of PVR
The stakeholders consulted indicated that introduction of the PVR is likely to be acceptable to Nigerian
society and fills a large gap in unmet family planning
need. Research and input from medical professionals,
politicians, senior government officials, religious and
traditional leaders, and international and local nongovernmental organizations show that there is a need
for a contraceptive that requires little training on the
part of the provider; does not require a sophisticated
health infrastructure; is very safe and long-acting and

thus does not require monthly visits to a health center; is user-friendly and woman-controlled; and sees a
quick return of fertility following discontinuation of the
method. The PVR addresses all of these concerns and
discussions with stakeholders indicate that it would be
a welcome addition to the existing mix of contraceptive
methods.

Historically there have been religious-based antagonists of family planning methods in the country. They
may be opposed to the PVR simply because it is a modern form of contraception. To date, no group has voiced
any opposition to the PVR.

Policymakers and stakeholders in Nigeria perceive
the vaginal ring innovation as a potential product to fill
the contraceptive gap, especially for women in northern Nigeria, in the immediate postpartum period. Thus
many stakeholders believe that the progesterone vaginal
ring would be highly favored by northern clients as it is
user-friendly, long-acting, does not require sophisticated
health infrastructure, has a high safety profile, requires
minimal facility visits, and fertility returns immediately
after discontinuation of use.
In general, stakeholders in Nigeria welcome the
vaginal ring and describe it as a major breakthrough in
expanding contraceptive method choice. It would further
empower women in the southern region to take control
of their reproductive health. Moreover, it would be especially appropriate and suitable for women in the North
who access healthcare facilities much less frequently,
due to an aversion toward male healthcare providers,
frequent need for permission from male partners to visit
health facilities, poverty, and a lack of skilled personnel.

The PVR would be a welcomed
method as it reduces facility
visits, is user-controlled, can be
inserted and removed by women
themselves, and requires minimal
counseling and instruction on
proper use. It would also further
empower women in the southern
region to take charge of their
reproductive lives.
	
  

Stakeholders did express some uncertainty that the
ring might make intercourse uncomfortable, which could
affect its popularity. However explanation, demonstration, and the testimony of satisfied clients assuaged
these concerns.

Stakeholders have deemed
the PVR to be highly
acceptable within the context
of the country’s family
planning services because the
product delivers progesterone,
a hormone already available in
various forms in Nigeria.
	
  

The main lesson to take away from the example of
Jadelle is cost-appropriateness. At present, all family
planning commodities are free in Nigeria provided that
they are accessed at public facilities, but when Jadelle
was first introduced they were not. Initially, when Jadelle
was distributed to stakeholders and clients, it was highly
popular. However, there was no arrangement in place
to ensure its continuous availability at a subsidized and
affordable price. Ordinary Nigerians could not afford
it at private market price, thus, the initial enthusiasm
abated. This experience must be considered as the PVR
is being introduced in Nigeria. The design of the PVR is
likely going to mitigate part of this problem. Developing a
strategic plan for eventual introduction of the product is
an appropriate approach.

Required Resources
Stakeholder interviews revealed key resources that were
recommended to ensure successful future introduction
of the PVR:
1.

Competent team members

2.

Local advocates

3.

Good product image

4.

Timely feedback

5.

Local experts
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DISCUSSION
Over the past decade in Nigeria, both the contraceptive
prevalence rate and the high unmet need for contraception have remained fairly static. Likewise, maternal and
infant mortality rates and other reproductive health indices have not changed significantly. As stated elsewhere,
multiple reinforcing factors are at fault, both individually
and in concert. Lack of availability and access to longacting contraceptives, lack of skilled providers to provide
implants and IUCDs, fragile health infrastructure, and
limited options for postpartum family planning are prominent among the numerous obstacles to widespread use
of family planning in Nigeria.
This rapid assessment of the contraceptive landscape in Nigeria has brought to light the huge demand
for further expanding the contraceptive method mix,
and specifically, the key role that PVR would play in this
respect. For example, married women in Nigeria prefer progestogens injectables (either Depo Provera or
Noristerat). These require multiple facility visits and the
presence of skilled providers for administration. Some
of these providers are male with whom contact is not
favored by women in northern Nigeria for cultural and religious reasons. The PVR can be inserted by the woman
herself with minimal coaching, obviating the need for
frequent visits to health facilities, skilled service providers, and contact with male providers. The use of other
postpartum family planning methods, such as Norplant
and IUCDs, is also a challenge due to a lack of skilled
providers. All these factors highlight the programmatic
gaps that the PVR can potentially fill.
For the PVR to be fully efficacious for contraception,
good breastfeeding practice is mandatory. Specifically,
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four breastfeeding episodes are required. Given the
breastfeeding culture in Nigeria where almost all infants
are breastfed (97%), the PVR has found a friendly environment. Since only 13% of breastfeeding women exclusively breastfeed by six months, the LAM method will not
suffice and effective supplementation is highly desirable,
and the PVR fulfills these needs. Although eligibility cannot translate to acceptability, experience with the PVR
so far has demonstrated a high level of acceptability in
environments where it is intensely studied such as numerous countries in Latin America, Egypt, and India.
One global discussion that bears mentioning is the
relationship between hormonal contraceptives and the
risk of HIV transmission. However, such concerns were
only expressed in research settings and academia, and
not yet at the population and policy levels. The recent
declaration by the World Health Organization advisory
committee dispels this concern and recommends continuous use of hormonal methods in all client subgroups.
It is worth noting that prior research has indicated an
increased prevalence of vaginal infection among postpartum women in Nigeria. This acceptability study will
carefully select women with vaginal infection for further
management before enrollment.
One challenge that must be considered is the cost
of this ring when it is finally introduced into the Nigerian
market. Currently, the Nigerian government policy on
family planning offers all contraceptives at public facilities free of charge provided they are available. Therefore,
for the PVR to compete favorably, the unit cost must be
competitive. This is one of the reasons why the federal
government of Nigeria, through the Federal Ministry of
Health, has been engaged in this effort from the outset.

List of Stakeholders Interviewed

1. Director, Department of Family Health, Federal
Ministry of Health, Federal Secretariat Complex,
Abuja
2. Director, Hospital Services Department, Federal
Secretariat, Federal Secretariat Complex, Abuja
3. The Chairman, Senate Committee on Health,
National Assembly Complex, Abuja, Nigeria
4. Director, Center for Reproductive Health and
Population, University College Hospital, Ibadan
5. Director General, National Agency for Foods,
Drugs Administration, and Control, Abuja, Nigeria
6. Director General, Nigerian Institute for Medical
Research, Yaba, Lagos, Nigeria
7.

Director of Research and Statistics, National
Population Commission of Nigeria, Abuja

8. Head, Maternal and Child Health, USAID, Murjanatu House, Abuja, Nigeria
9. The Nigerian Urban Reproductive Health Initiative,
St. James’ House, Wuse, Abuja
10. The President/CEO, Association of Reproductive
and Family Health, Millennium Builders’ Plaza,
Central Business District, Abuja

12. Executive Director, Women’s Health and Action
Research Center, Benin City, Nigeria
13. Registrar/CEO, Pharmacists Council of Nigeria,
Idu Industrial Area, Garki, Abuja
14. The Registrar, Nursing and Midwifery Council of
Nigeria, Abuja
15. Executive Director, Development Communication
Network, Surulere, Lagos
16. Executive Director, Center for Communication
Programs—Nigeria, Maitama, Abuja
17. Federation of Muslim Women’s Association of
Nigeria, Maitama, Abuja
18. The President, Association of Community Pharmacist Practitioners, Abuja, Nigeria
19. Department of Obstetrics and Gynecology, University College Hospital, Ibadan
20. Medical Director, Wuse General Hospital, Abuja
21. Society for Family Health, Area 11, Garki, Abuja
22. Gender and Development Specialist, United Nation Children’s Fund, UN House, Abuja

11. Advocacy Nigeria/Family Planning Action Group,
Lobito Crescent, Wuse 11, Abuja
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